Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 26, 2021

SELL
$10.34 - $12.81 $525,447 - $650,965
-50,817 Closed
0 $0
Q3 2020

Oct 19, 2020

BUY
$8.57 - $12.69 $435,501 - $644,867
50,817 New
50,817 $458,000
Q1 2020

Apr 16, 2020

SELL
$6.69 - $13.45 $28,880 - $58,063
-4,317 Closed
0 $0
Q4 2019

Jan 17, 2020

BUY
$6.53 - $10.72 $28,190 - $46,278
4,317 New
4,317 $42,000
Q3 2019

Oct 24, 2019

SELL
$6.16 - $9.6 $91,488 - $142,579
-14,852 Closed
0 $0
Q2 2019

Aug 05, 2019

BUY
$8.12 - $15.72 $120,598 - $233,473
14,852 New
14,852 $137,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.3B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Brave Asset Management Inc Portfolio

Follow Brave Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brave Asset Management Inc with notifications on news.